The carboxyl-terminal sequence of bim enables bax activation and killing of unprimed cells

Author:

Chi Xiaoke12ORCID,Nguyen Dang23,Pemberton James M23ORCID,Osterlund Elizabeth J24,Liu Qian2,Brahmbhatt Hetal125,Zhang Zhi67,Lin Jialing67ORCID,Leber Brian5,Andrews David W234ORCID

Affiliation:

1. Department of Chemistry and Chemical Biology, McMaster University, Hamilton, Canada

2. Biological Sciences, Sunnybrook Research Institute, Toronto, Canada

3. Department of Medical Biophysics, University of Toronto, Ontario, Canada

4. Department of Biochemistry, University of Toronto, Toronto, Canada

5. Department of Medicine, McMaster University, Hamilton, Canada

6. Department of Biochemistry, University of Oklahoma Health Sciences Center, Oklahoma City, United States

7. Molecular Biology and Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, United States

Abstract

The Bcl-2 family BH3 protein Bim promotes apoptosis at mitochondria by activating the pore-forming proteins Bax and Bak and by inhibiting the anti-apoptotic proteins Bcl-XL, Bcl-2 and Mcl-1. Bim binds to these proteins via its BH3 domain and to the mitochondrial membrane by a carboxyl-terminal sequence (CTS). In cells killed by Bim, the expression of a Bim mutant in which the CTS was deleted (BimL-dCTS) triggered apoptosis that correlated with inhibition of anti-apoptotic proteins being sufficient to permeabilize mitochondria isolated from the same cells. Detailed analysis of the molecular mechanism demonstrated that BimL-dCTS inhibited Bcl-XL but did not activate Bax. Examination of additional point mutants unexpectedly revealed that the CTS of Bim directly interacts with Bax, is required for physiological concentrations of Bim to activate Bax and that different residues in the CTS enable Bax activation and binding to membranes.

Funder

Canadian Institutes of Health Research

National Institutes of Health

Oklahoma Center for the Advancement of Science and Technology

Presbyterian Health Foundation

Canada Research Chairs

Canadian Breast Cancer Foundation

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3